Robert Liu

Managing Director, CDIB Yida Healthcare Private Equity Fund

Achievement
More than US$3bn worth of M&A deals and investment transactions in the US, Europe, and Asia.
Career
Principal, Venture Investments
Johnson & Johnson Development Corporation
Director of Business Development & Strategy
GlaxoSmithKline, Greater China
Senior Associate
Charles River Laboratories
The best preparation for tomorrow is doing you best today.
Education & Honor
University of Rochester
PhD in Pharmacology
University of Chicago
MBA at Booth School of Business
Key Experience
Focus on Venture and Private Equity of Healthcare Fund
Prior to joining CDIB, Robert was responsible for venture and private equity investments in life sciences and healthcare in the Asia Pacific region at Johnson & Johnson Development Corporation (JJDC).
Expert of M&A Deals and Investment Transactions
Prior to JJDC, Robert served as Director of Business Development & Strategy in Greater China at GlaxoSmithKline, and worked in the Global Corporate Development & Strategy team of Charles River Laboratories in Boston. He has executed over US$3bn worth of M&A deals and investment transactions in the US, Europe, and Asia.
MEET OUR PRESIDENT OF CDIB YIDA PRIVATE EQUITY (KUNSHAN) CO. LTD.
Yen Lu